Annual CFF
$262.00 M
+$417.20 M+268.81%
December 31, 2024
Summary
- As of March 12, 2025, SGRY annual cash flow from financing activities is $262.00 million, with the most recent change of +$417.20 million (+268.81%) on December 31, 2024.
- During the last 3 years, SGRY annual CFF has fallen by -$54.30 million (-17.17%).
- SGRY annual CFF is now -17.17% below its all-time high of $316.30 million, reached on December 31, 2021.
Performance
SGRY Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$48.00 M
+$55.30 M+757.53%
December 31, 2024
Summary
- As of March 12, 2025, SGRY quarterly cash flow from financing activities is $48.00 million, with the most recent change of +$55.30 million (+757.53%) on December 31, 2024.
- Over the past year, SGRY quarterly CFF has stayed the same.
- SGRY quarterly CFF is now -79.11% below its all-time high of $229.80 million, reached on December 31, 2021.
Performance
SGRY Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$262.00 M
+$92.60 M+54.66%
December 31, 2024
Summary
- As of March 12, 2025, SGRY TTM cash flow from financing activities is $262.00 million, with the most recent change of +$92.60 million (+54.66%) on December 31, 2024.
- Over the past year, SGRY TTM CFF has stayed the same.
- SGRY TTM CFF is now -17.17% below its all-time high of $316.30 million, reached on December 31, 2021.
Performance
SGRY TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SGRY Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +268.8% | 0.0% | 0.0% |
| 3 y3 years | -17.2% | -79.1% | -17.2% |
| 5 y5 years | +292.8% | -79.1% | -17.2% |
SGRY Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.2% | +268.8% | -79.1% | +180.9% | -17.2% | +268.8% |
| 5 y | 5-year | -17.2% | +268.8% | -79.1% | +180.9% | -17.2% | +268.8% |
| alltime | all time | -17.2% | +268.8% | -79.1% | +180.9% | -17.2% | +268.8% |
Surgery Partners Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $262.00 M(-268.8%) | $48.00 M(-757.5%) | $262.00 M(+54.7%) |
| Sep 2024 | - | -$7.30 M(-103.9%) | $169.40 M(+8.4%) |
| Jun 2024 | - | $189.60 M(+498.1%) | $156.30 M(-289.9%) |
| Mar 2024 | - | $31.70 M(-171.1%) | -$82.30 M(-47.0%) |
| Dec 2023 | -$155.20 M(-468.6%) | -$44.60 M(+118.6%) | -$155.20 M(-288.1%) |
| Sep 2023 | - | -$20.40 M(-58.4%) | $82.50 M(+50.3%) |
| Jun 2023 | - | -$49.00 M(+18.9%) | $54.90 M(+23.1%) |
| Mar 2023 | - | -$41.20 M(-121.3%) | $44.60 M(+5.9%) |
| Dec 2022 | $42.10 M(-86.7%) | $193.10 M(-502.3%) | $42.10 M(-46.6%) |
| Sep 2022 | - | -$48.00 M(-19.1%) | $78.80 M(+0.4%) |
| Jun 2022 | - | -$59.30 M(+35.7%) | $78.50 M(-7.4%) |
| Mar 2022 | - | -$43.70 M(-119.0%) | $84.80 M(-73.2%) |
| Dec 2021 | $316.30 M(+374.2%) | $229.80 M(-575.8%) | $316.30 M(+677.1%) |
| Sep 2021 | - | -$48.30 M(-8.9%) | $40.70 M(-74.0%) |
| Jun 2021 | - | -$53.00 M(-128.2%) | $156.50 M(-10.1%) |
| Mar 2021 | - | $187.80 M(-510.0%) | $174.10 M(+161.0%) |
| Dec 2020 | $66.70 M(-149.1%) | -$45.80 M(-167.9%) | $66.70 M(-27.4%) |
| Sep 2020 | - | $67.50 M(-290.7%) | $91.90 M(-566.5%) |
| Jun 2020 | - | -$35.40 M(-144.0%) | -$19.70 M(+69.8%) |
| Mar 2020 | - | $80.40 M(-490.3%) | -$11.60 M(-91.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$135.90 M(+2057.1%) | -$20.60 M(-53.3%) | -$135.90 M(-2128.4%) |
| Sep 2019 | - | -$44.10 M(+61.5%) | $6.70 M(-58.4%) |
| Jun 2019 | - | -$27.30 M(-37.8%) | $16.10 M(+192.7%) |
| Mar 2019 | - | -$43.90 M(-136.0%) | $5.50 M(-187.3%) |
| Dec 2018 | -$6.30 M(-108.8%) | $122.00 M(-451.6%) | -$6.30 M(-95.1%) |
| Sep 2018 | - | -$34.70 M(-8.4%) | -$128.30 M(+37.1%) |
| Jun 2018 | - | -$37.90 M(-32.0%) | -$93.60 M(+74.4%) |
| Mar 2018 | - | -$55.70 M(-2834.4%) | -$53.66 M(+147.7%) |
| Jun 2017 | - | $2.04 M(-104.9%) | -$21.66 M(-47.7%) |
| Mar 2017 | - | -$41.98 M(-436.7%) | -$41.42 M(-158.1%) |
| Dec 2016 | $71.28 M(+113.6%) | $12.47 M(+114.5%) | $71.28 M(-45.6%) |
| Sep 2016 | - | $5.81 M(-132.8%) | $131.06 M(-0.4%) |
| Jun 2016 | - | -$17.73 M(-125.1%) | $131.63 M(+3.7%) |
| Mar 2016 | - | $70.72 M(-2.1%) | $126.89 M(+280.2%) |
| Dec 2015 | $33.37 M(-89.3%) | $72.25 M(+1033.0%) | $33.37 M(-185.8%) |
| Sep 2015 | - | $6.38 M(-128.4%) | -$38.88 M(-14.1%) |
| Jun 2015 | - | -$22.46 M(-1.5%) | -$45.26 M(+98.5%) |
| Mar 2015 | - | -$22.79 M | -$22.79 M |
| Dec 2014 | $310.96 M(-925.7%) | - | - |
| Dec 2013 | -$37.66 M(-12.5%) | - | - |
| Dec 2012 | -$43.06 M | - | - |
FAQ
- What is Surgery Partners annual cash flow from financing activities?
- What is the all time high annual CFF for Surgery Partners?
- What is Surgery Partners annual CFF year-on-year change?
- What is Surgery Partners quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Surgery Partners?
- What is Surgery Partners quarterly CFF year-on-year change?
- What is Surgery Partners TTM cash flow from financing activities?
- What is the all time high TTM CFF for Surgery Partners?
- What is Surgery Partners TTM CFF year-on-year change?
What is Surgery Partners annual cash flow from financing activities?
The current annual CFF of SGRY is $262.00 M
What is the all time high annual CFF for Surgery Partners?
Surgery Partners all-time high annual cash flow from financing activities is $316.30 M
What is Surgery Partners annual CFF year-on-year change?
Over the past year, SGRY annual cash flow from financing activities has changed by +$417.20 M (+268.81%)
What is Surgery Partners quarterly cash flow from financing activities?
The current quarterly CFF of SGRY is $48.00 M
What is the all time high quarterly CFF for Surgery Partners?
Surgery Partners all-time high quarterly cash flow from financing activities is $229.80 M
What is Surgery Partners quarterly CFF year-on-year change?
Over the past year, SGRY quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Surgery Partners TTM cash flow from financing activities?
The current TTM CFF of SGRY is $262.00 M
What is the all time high TTM CFF for Surgery Partners?
Surgery Partners all-time high TTM cash flow from financing activities is $316.30 M
What is Surgery Partners TTM CFF year-on-year change?
Over the past year, SGRY TTM cash flow from financing activities has changed by $0.00 (0.00%)